Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction

This publication has 17 references indexed in Scilit:

• Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction
  Circulation, 2003
• Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure
  Cardiovascular Research, 2002
• Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing–Induced Congestive Heart Failure
  Circulation, 2001
• Trandolapril Reduces the Incidence of Atrial Fibrillation After Acute Myocardial Infarction in Patients With Left Ventricular Dysfunction
  Circulation, 1999
• Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials
  Journal of the American College of Cardiology, 1998
• Improving survival for patients with atrial fibrillation and advanced heart failure
  Journal of the American College of Cardiology, 1996
• Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
  New England Journal of Medicine, 1992
• Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
  New England Journal of Medicine, 1991
• The effect of atrial dilatation on the genesis of atrial arrhythmias
  Cardiovascular Research, 1989
• Epidemiologic Features of Chronic Atrial Fibrillation
  New England Journal of Medicine, 1982